Citation: K. Mertins et al., INTEGRATING BUSINESS-PROCESS REENGINEERING WITH HUMAN-RESOURCE DEVELOPMENT FOR CONTINUOUS IMPROVEMENT, International journal of technology management, 14(1), 1997, pp. 39-49
Authors:
JURGENS J
SCHEDLETZKY H
HEISIG P
SEYDEL JK
WIEDEMANN B
HOLZGRABE U
Citation: J. Jurgens et al., SYNTHESES AND BIOLOGICAL-ACTIVITIES OF NEW N-1-ARYL SUBSTITUTED QUINOLONE ANTIBACTERIALS, Archiv der pharmazie, 329(4), 1996, pp. 179-190
Citation: P. Heisig, GENETIC-EVIDENCE FOR A ROLE OF PARC MUTATIONS IN DEVELOPMENT OF HIGH-LEVEL FLUOROQUINOLONE RESISTANCE IN ESCHERICHIA-COLI, Antimicrobial agents and chemotherapy, 40(4), 1996, pp. 879-885
Authors:
HEISIG P
KRATZ B
HALLE E
GRASER Y
ALTWEGG M
RABSCH W
FABER JP
Citation: P. Heisig et al., IDENTIFICATION OF DNA GYRASE A MUTATIONS IN CIPROFLOXACIN-RESISTANT ISOLATES OF SALMONELLA-TYPHIMURIUM FROM MEN AND CATTLE IN GERMANY, Microbial drug resistance, 1(3), 1995, pp. 211-218
Authors:
SPEICH N
DAHL C
HEISIG P
KLEIN A
LOTTSPEICH F
STETTER KO
TRUPER HG
Citation: N. Speich et al., ADENYLYLSULPHATE REDUCTASE FROM THE SULFATE-REDUCING ARCHAEON ARCHAEOGLOBUS-FULGIDUS - CLONING AND CHARACTERIZATION OF THE GENES AND COMPARISON OF THE ENZYME WITH OTHER IRON-SULFUR FLAVOPROTEINS, Microbiology, 140, 1994, pp. 1273-1284
Citation: B. Wiedemann et P. Heisig, QUINOLONE RESISTANCE IN GRAM-NEGATIVE BACTERIA, Infectious diseases in clinical practice, 3, 1994, pp. 190000115-190000124
Authors:
HEISIG P
TZOUVELEKIS L
VATOPOULOS A
LEGAKIS N
Citation: P. Heisig et al., CIPROFLOXACIN RESISTANCE IN ENTEROBACTERIAL CLINICAL ISOLATES, Journal of antimicrobial chemotherapy, 33(4), 1994, pp. 887-888
Authors:
NABER KG
WITTE W
BAUERNFEIND A
WIEDEMANN B
WAGENLEHNER F
KLARE I
HEISIG P
Citation: Kg. Naber et al., CLINICAL-SIGNIFICANCE AND SPREAD OF FLUOROQUINOLONE RESISTANT UROPATHOGENS IN HOSPITALIZED UROLOGICAL PATIENTS, Infection, 22, 1994, pp. 190000122-190000127
Citation: P. Heisig et R. Tschorny, CHARACTERIZATION OF FLUORO QUINOLONE-RESISTANT MUTANTS OF ESCHERICHIA-COLI SELECTED IN-VITRO, Antimicrobial agents and chemotherapy, 38(6), 1994, pp. 1284-1291
Citation: P. Heisig, HIGH-LEVEL FLUOROQUINOLONE RESISTANCE IN A SALMONELLA-TYPHIMURIUM ISOLATE DUE TO ALTERATIONS IN BOTH GYRA AND GYRB GENES, Journal of antimicrobial chemotherapy, 32(3), 1993, pp. 367-377